About the Startup
UK-based biotech advancing immunotherapeutic antimicrobial programs. Developing CTX-187 (ABX-01 programme), a broad-spectrum immunotherapeutic designed to treat multidrug-resistant Gram-negative bacterial infections using a dual mechanism of action.
Frequently Asked Questions
What type of funding round did Centauri Therapeutics raise?
Centauri Therapeutics raised a unspecified round.
How much did Centauri Therapeutics raise in its unspecified?
Centauri Therapeutics raised $5,100,000 USD in its unspecified.
Who invested in Centauri Therapeutics's unspecified?
The investors in Centauri Therapeutics's unspecified are: CARB-X.
What type of investment was Centauri Therapeutics's unspecified?
Centauri Therapeutics's unspecified was a equity investment.